Charmacy Pharmaceutical Co., Ltd. (02289)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Li Hanguo31-May-23INED
Xu Fei31-May-23NED
Yan Jingbin31-May-23Ch, NED
Yao Chuanglong31-May-23CEO, V-Ch
Zhang Ling31-May-23Sup
Zhu Minghong31-May-23ChSup
Fu Zheng13-Jul-22NED
Zhang Hanzi13-Jul-22ED
Yao Jiexi08-Apr-22CoSec
Wong Wai Ling08-Apr-22CoSec
Guan Jian01-Dec-15INED
Wan Anthony Chi Wai01-Dec-15INED
Zheng Xiyue25-May-15Sup
Zheng Yuyan25-May-15ED, VP
Dong JianfengSen Mgr
Xiang ZhixiongSen Mgr
Wong Wai Ling08-Apr-2227-Mar-26J-CoSecTendered her resignation.
Yao Chuanglong27-Jun-25MbNCCeased to be a member of the Nomination Committee in response to amendments to the Listing Rules and the Corporate Governance Code, effective 1 July 2025.
Lin Zhijie05-Sep-1731-May-23Sup
Yan Jingbin06-Jun-2231-May-23NED
Yao Chuanglong25-May-1531-May-23Ch, CEO
Zhang Ling25-May-1531-May-23ChSup
Zhou Tao01-Dec-1531-May-23INEDDue to the need to devote more effort to other personal work matters
Lin Zhijie31-May-23Shareholder Representative SupervisorDue to the need to devote more effort to work matters
Yao Chuanglong31-May-23Chairman of the BoardFor purposes of meeting the operation management needs of the Company, strengthening the division of functions and powers, improving the corporate governance structure, and compliance with the requirement of code provision C.2.1 of the Corporate Governance Code set out in Appendix 14 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited
Zhang Ling31-May-23Chairlady of the Board of SupervisorsDue to the need to devote more effort in handling other personal affairs
Li Weisheng10-Jun-1717-Apr-23NEDDue to the need to devote more effort to other personal work matter
Lin Zhixiong08-Apr-22CoSec, EDthe pursuit of his other personal career development
Lin Zhixiong25-May-1508-Apr-22FD
Ng Wing Shan01-Dec-1528-Jan-19CoSec
Lin Zhijie05-Sep-17Sen Mgr
You Zeyan25-May-1505-Sep-17NED
Zhang Hanzi25-May-1505-Sep-17Sup
Fan Jianbo25-May-1519-Jul-17ED, VP
Yao Chuanglong06-Mar-0025-May-15ED